HE4 elevation obviously increased with advanced renal fibrosis stage, and ROC analysis showed HE4 as a suitable biomarker, which was more sensitive than serum creatinine for the diagnosis of renal fibrosis in CKD patients. This evidence concerns the gene WFDC2 and chronic kidney disease.